Open access · CC-BY
via OpenAlex
Organ‐Specific Dedifferentiation and Epigenetic Remodeling in In Vivo Reprogramming
Beom‐Ki Jo, Seungyeon Lee, Hee‐Ji Eom, Jumee Kim, Hyuk‐Jin Cha
Aging Cell · 2025 · ▲ 6 citations
Abstract
The advent of in vivo reprogramming through transient expression of the Yamanaka factors (OCT4, SOX2, KLF4, and c-MYC) holds strong promise for regenerative medicine, despite ongoing concerns about safety and clinical applicability. This review synthesizes recent advances in in vivo reprogramming, focusing on its potential to restore regenerative competence and promote rejuvenation across diverse tissues, including the retina, skeletal muscle, heart, liver, brain, and intestine. We highlight mechanistic parallels and distinctions between injury-induced dedifferentiation and OSKM-mediated reprogramming, emphasizing the roles of dedifferentiation, transient regenerative progenitors, and epigenetic remodeling. Critical safety considerations-such as teratoma formation, organ failure, and loss of cell identity-are discussed alongside strategies designed to mitigate these risks, like cyclic induction and targeted delivery. Finally, we briefly note the growing translational interest in this field, alongside directing readers to recent reviews for detailed coverage of biotech initiatives. Collectively, this work underscores the transformative potential of in vivo reprogramming for both tissue regeneration and rejuvenation, while stressing the importance of precise spatiotemporal control for its safe clinical application.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/acel.70268
- Canonical
- link ↗
- Fetched
- 2026-08-28 MST
Cite this
APA
Jo, B., Lee, S., Eom, H., Kim, J., & Cha, H. (2025). Organ‐Specific Dedifferentiation and Epigenetic Remodeling in In Vivo Reprogramming. <em>Aging Cell</em>. https://doi.org/10.1111/acel.70268
Vancouver
Jo B, Lee S, Eom H, Kim J, Cha H. Organ‐Specific Dedifferentiation and Epigenetic Remodeling in In Vivo Reprogramming. Aging Cell. 2025. doi:10.1111/acel.70268.
BibTeX
@article{beomki2025OrganS,
title = {Organ‐Specific Dedifferentiation and Epigenetic Remodeling in In Vivo Reprogramming},
author = {Beom‐Ki Jo and Seungyeon Lee and Hee‐Ji Eom and Jumee Kim and Hyuk‐Jin Cha},
journal = {Aging Cell},
year = {2025},
doi = {10.1111/acel.70268},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging cell 2025
Open access · OA
Organ-Specific Dedifferentiation and Epigenetic Remodeling in In Vivo Reprogramming.
Cell Reports Medicine 2026
Open access · CC-BY
Enhanced liver regeneration via targeted mRNA delivery for partial in vivo reprogramming
Journal of Advanced Research 2025
Open access · CC-BY
Developing chemical reprogramming strategies of non-hepatocytes for liver regeneration
Current Opinion in Genetics & Development 2025
Open access · CC-BY
Unlocking regeneration: how partial reprogramming resembles tissue healing
Clinical Epigenetics 2021
Open access · CC-BY
Cellular reprogramming and epigenetic rejuvenation
Central Asian Journal of Medical Hypotheses and Ethics 2026
Open access · CC-BY